Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free TLM Stock Alerts

Talisman Metals (TLM) Competitors

GBX 7.47 +0.22 (+3.03%)
As of 07/13/2026 11:53 AM Eastern
Compare

TLM vs. IXI, APTA, FAB, RLM, and NSCI

Should you buy Talisman Metals stock or one of its competitors? MarketBeat compares Talisman Metals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Talisman Metals include IXICO (IXI), Aptamer Group (APTA), Fusion Antibodies (FAB), Realm Therapeutics (RLM), and NetScientific (NSCI). These companies are all part of the "biotechnology" industry.

How does Talisman Metals compare to IXICO?

IXICO (LON:IXI) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Talisman Metals has a net margin of 0.00% compared to IXICO's net margin of -24.98%. IXICO's return on equity of -16.18% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
IXICO-24.98% -16.18% -10.40%
Talisman Metals N/A -32.71%3.70%

IXICO has a beta of 0.129, suggesting that its share price is 87% less volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Talisman Metals has lower revenue, but higher earnings than IXICO. IXICO is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IXICO£7.28M2.50-£3.58M-£1.95N/A
Talisman MetalsN/AN/A-£1.35M£12.390.60

In the previous week, IXICO had 5 more articles in the media than Talisman Metals. MarketBeat recorded 6 mentions for IXICO and 1 mentions for Talisman Metals. IXICO's average media sentiment score of 0.06 beat Talisman Metals' score of 0.00 indicating that IXICO is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IXICO
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Talisman Metals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

13.0% of IXICO shares are held by institutional investors. Comparatively, 1.4% of Talisman Metals shares are held by institutional investors. 3.0% of IXICO shares are held by insiders. Comparatively, 95.2% of Talisman Metals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Talisman Metals beats IXICO on 7 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to Aptamer Group?

Talisman Metals (LON:TLM) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Aptamer Group has a beta of 0.899, indicating that its share price is 10% less volatile than the broader market.

Talisman Metals has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Talisman Metals' return on equity of -32.71% beat Aptamer Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Aptamer Group -178.52%-135.35%-44.96%

Talisman Metals has higher earnings, but lower revenue than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.60
Aptamer Group£1.38M11.28-£14.17M-£0.11N/A

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 3.0% of Aptamer Group shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 7.3% of Aptamer Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Talisman Metals had 1 more articles in the media than Aptamer Group. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Aptamer Group. Talisman Metals' average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Aptamer Group Neutral

Summary

Talisman Metals beats Aptamer Group on 9 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Fusion Antibodies?

Fusion Antibodies (LON:FAB) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Talisman Metals has a net margin of 0.00% compared to Fusion Antibodies' net margin of -91.92%. Talisman Metals' return on equity of -32.71% beat Fusion Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Fusion Antibodies-91.92% -210.32% -63.78%
Talisman Metals N/A -32.71%3.70%

Fusion Antibodies has a beta of 1.224, meaning that its stock price is 22% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

7.6% of Fusion Antibodies shares are held by institutional investors. Comparatively, 1.4% of Talisman Metals shares are held by institutional investors. 5.9% of Fusion Antibodies shares are held by insiders. Comparatively, 95.2% of Talisman Metals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Talisman Metals had 1 more articles in the media than Fusion Antibodies. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Fusion Antibodies. Fusion Antibodies' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Fusion Antibodies Neutral
Talisman Metals Neutral

Talisman Metals has lower revenue, but higher earnings than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fusion Antibodies£1.60M8.47-£4.10M-£1.50N/A
Talisman MetalsN/AN/A-£1.35M£12.390.60

Summary

Talisman Metals beats Fusion Antibodies on 8 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Realm Therapeutics?

Realm Therapeutics (LON:RLM) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Realm Therapeutics has higher revenue and earnings than Talisman Metals. Realm Therapeutics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Realm Therapeutics£501.92K0.00N/A-£17.50N/A
Talisman MetalsN/AN/A-£1.35M£12.390.60

In the previous week, Talisman Metals had 1 more articles in the media than Realm Therapeutics. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Realm Therapeutics. Realm Therapeutics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Realm Therapeutics Neutral
Talisman Metals Neutral

1.4% of Talisman Metals shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Realm Therapeutics' return on equity of 0.00% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Realm TherapeuticsN/A N/A N/A
Talisman Metals N/A -32.71%3.70%

Summary

Talisman Metals beats Realm Therapeutics on 6 of the 8 factors compared between the two stocks.

How does Talisman Metals compare to NetScientific?

Talisman Metals (LON:TLM) and NetScientific (LON:NSCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 14.7% of NetScientific shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 42.4% of NetScientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Talisman Metals had 1 more articles in the media than NetScientific. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for NetScientific. Talisman Metals' average media sentiment score of 0.00 equaled NetScientific'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
NetScientific Neutral

Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, NetScientific has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Talisman Metals has higher earnings, but lower revenue than NetScientific. NetScientific is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.60
NetScientific£1.45M0.00-£2.64M-£0.11N/A

Talisman Metals has a net margin of 0.00% compared to NetScientific's net margin of -182.91%. NetScientific's return on equity of -13.70% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
NetScientific -182.91%-13.70%-9.42%

Summary

Talisman Metals beats NetScientific on 7 of the 11 factors compared between the two stocks.

Get Talisman Metals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLM vs. The Competition

Export
MetricTalisman MetalsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.79M£517.61M£7.05B£2.84B
Dividend Yield0.83%3.90%2.68%6.17%
P/E Ratio0.603.4727.15368.18
Price / SalesN/A6,436.17587.9284,612.72
Price / Cash1.0013.1329.2227.87
Price / Book3.1085.9310.757.49
Net Income-£1.35M-£96.07M£3.58B£5.89B
7 Day Performance-0.40%-1.18%-2.10%-0.48%
1 Month Performance-1.84%2.45%3.32%-1.00%
1 Year PerformanceN/A60.93%28.17%61.74%

Talisman Metals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLM
Talisman Metals
N/AGBX 7.47
+3.0%		N/AN/A£4.79MN/A0.605
IXI
IXICO
N/AGBX 8.50
+3.0%		N/A-16.2%£18.53M£7.28MN/A89
APTA
Aptamer Group
N/AGBX 0.47
-1.1%		N/A+11.4%£16.24M£1.38MN/A37
FAB
Fusion Antibodies
N/AGBX 11.50
-4.2%		N/A+68.8%£14.38M£1.60MN/A48
RLM
Realm Therapeutics
N/AN/AN/AN/A£13.41M£501.92KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TLM) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Print this and keep it by your screen
Ever been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...
Profits Run | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel